Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus

Neuroscience Letters

Volumn 249, Issue 2-3, 1998, Pages 151-154

  Honey, C R ^a   Shen, H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

6 hydroxydopamine; Apomorphine; Circling behaviour; Entopeduncular nucleus; Levodopa; Rodent; Substantia nigra pars reticulata; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ANIMAL EXPERIMENT; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; ENTOPEDUNCULAR NUCLEUS; NERVE TRACT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; BENSERAZIDE; CORPUS STRIATUM; DOPAMINE AGENTS; DOPAMINE AGONISTS; INJECTIONS, INTRAPERITONEAL; LEVODOPA; MALE; MOTOR ACTIVITY; OXIDOPAMINE; QUINOLINIC ACID; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; THALAMIC NUCLEI;

EID: 0032547045     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00431-5     Document Type: Article

References (20)

1. Ariano M.A., Engber T.M., Susel Z., Chase T.N. Striatal D1 dopamine receptor morphochemistry following continuous or intermittent levodopa replacement therapy. Exp. Neurol. 112:1991;112-118.
2. Engber T.M., Susel Z., Juncos J.L., Chase T.N. Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists. Eur. J. Pharmacol. 168:1989;291-298.
3. Engber T.M., Susel Z., Kuo S., Gerfen C.R., Chase T.N. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res. 552:1991;113-118.
4. Favre J., Taha J.M., Nguyen T.T., Gildenberg P.L., Burchiel K.J. Pallidotomy: a survey of current practice in North America. Neurosurgery. 39(4):1996;890-892.
5. Gnanalingham K.K., Robertson R.G. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats - an autoradiographic study using [3H]flunitrazepam. Neuroscience. 57(3):1993;673-681.
6. Gnanalingham K.K., Robertson R.G. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat - an autoradiographic study. Brain Res. 640:1994;185-194.
7. Jenner, P., Boyce, S. and Marsden, C.D., Effect of repeated L-DOPA administration on striatal dopamine receptor function in the rat. In S. Fahn, S.C. Marsden, P. Jenner and P. Teychenne (Eds.), Recent Developments in Parkinson's Disease, Raven, New York, 1986, pp. 189-203.
8. Juncos J.L., Engber T.M., Raisman R., Susel Z., Thibaut F., Ploska A., Agid Y., Chase T.N. Continuous and intermittent levodopa differentially affect basal ganglia function. Ann. Neurol. 25:1989;473-478.
9. Limousin P., Pollak P., Benazzouz A., Hoffmann D., LeBas J.F., Broussole E., Perret J.E., Benabid A.L. Effect on Parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345(8942):1995;91-95.
10. Marsden C.D., Parkes J.D. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet. 1:1977;345-349.
11. Mouradian M.M., Juncos J.L., Fabbrini G., Chase T.N. Motor fluctuations in Parkinson's disease: pathogenic and therapeutic studies. Ann. Neurol. 22:1987;475-479.
12. Mouradian M.M., Juncos J.L., Fabbrini G., Schlegel J., Bartko J.J., Chase T.N. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part II. Ann. Neurol. 24:1988;372-378.
13. Parenti M., Flauto C., Parati E., Vescovi A., Groppetti A. Differential effect of repeated treatment with levodopa on dopamine D1 or D2 receptors. Neuropharmacology. 25:1986;331-334.
14. Paxinos, G. And Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
15. Reches A., Wagner H.R., Jackson-Lewis V., Yablonskaya-Alter E., Fahn S. Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum. Neurology. 34:1984;1208-1212.
16. Rioux L., Gagnon C., Gaudin D.P., Di Paolo T., Bédard P.J. A fetal nigral graft prevents behavioural supersensitivity associated with repeated injections of L-DOPA in 6-OHDA rats. Correlation with D1 and D2 receptors. Neuroscience. 56(1):1993;45-51.
17. Rouillard C., Bebard P.J., Falardeau P., Dipaolo T. Behavioural and biochemical evidence for a different effect of repeated administration of L-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology. 26:1987;1601-1606.
18. Roy E., Côté P.-Y., Grégoire L., Parent A., Bédard P.J. Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine. Neuroscience. 66(2):1995;413-425.
19. Weick B.G., Engber T.M., Susel Z., Chase T.N., Walters J.R. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration. Brain Res. 523:1990;16-22.
20. Zeng B.Y., Jolkkonen J., Jenner P., Marsden C.D. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat. Neuroscience. 66(1):1995;19-25.